233 related articles for article (PubMed ID: 17586044)
1. PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
Leuk Res; 2008 Jan; 32(1):121-30. PubMed ID: 17586044
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
3. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
Atar O; Levi BZ
Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
5. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
6. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
[TBL] [Abstract][Full Text] [Related]
7. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
8. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
Fibach E; Reuben RC; Rifkind RA; Marks PA
Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
[TBL] [Abstract][Full Text] [Related]
9. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
10. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
[TBL] [Abstract][Full Text] [Related]
11. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
Breig O; Théoleyre O; Douablin A; Baklouti F
Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells.
Petrak J; Myslivcova D; Man P; Cmejlova J; Cmejla R; Vyoral D
Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068
[TBL] [Abstract][Full Text] [Related]
15. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
[TBL] [Abstract][Full Text] [Related]
16. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.
Ruscetti SK
J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells.
Mallia CM; Aguirre V; McGary E; Tang Y; Scandurro AB; Liu C; Noguchi CT; Beckman BS
Exp Cell Res; 1999 Feb; 246(2):348-54. PubMed ID: 9925750
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
[TBL] [Abstract][Full Text] [Related]
19. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
Yamashita T; Wakao H; Miyajima A; Asano S
Cancer Res; 1998 Feb; 58(3):556-61. PubMed ID: 9458105
[TBL] [Abstract][Full Text] [Related]
20. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
Starck J; Doubeikovski A; Sarrazin S; Gonnet C; Rao G; Skoultchi A; Godet J; Dusanter-Fourt I; Morle F
Mol Cell Biol; 1999 Jan; 19(1):121-35. PubMed ID: 9858537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
